Official Title
Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contact for Patient With COVID-19
Brief Summary
asymptomatic family close contact of confirmed COVID -19 patient will receive prophylactic ivermectin and will be followed up for 14 days for any symptoms & diagnosis of COVID -19
Completed
COVID
Drug: Ivermectin Tablets
two doses 72 hours apart
Eligibility Criteria
Inclusion Criteria:
family contact of confirmed COVID-19 case
Exclusion Criteria:
- refuse to participate and receive the drug pregnancy or lactation known
hypersensitivity to ivermectin
Eligibility Gender
All
Eligibility Age
Minimum: 16 Years ~ Maximum: 70 Years
Countries
Egypt
Locations
Zagazig University
Zagazig, Sharkia, Egypt
Zagazig University
NCT Number
MeSH Terms
Ivermectin